img

Global Viral Gastroenteritis Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Viral Gastroenteritis Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Global Viral Gastroenteritis Drugs market is projected to reach US$ 58 million in 2029, increasing from US$ 44 million in 2022, with the CAGR of 4.1% during the period of 2024 to 2029. Demand from Hospital and Clinic are the major drivers for the industry.
The Viral Gastroenteritis Drugs market is influenced by several trends that are shaping the development and availability of medications for this condition. Viral gastroenteritis, commonly known as the stomach flu, is caused by various viruses and is characterized by symptoms such as diarrhea, vomiting, abdominal pain, and fever.One major trend in the Viral Gastroenteritis Drugs market is the focus on supportive care and symptom management. Currently, there are no specific antiviral drugs available for the treatment of viral gastroenteritis. Therefore, the primary approach is to manage symptoms such as dehydration, nausea, and diarrhea. Oral rehydration solutions, anti-emetic medications, and anti-diarrheal agents are commonly used to alleviate symptoms and improve patient comfort.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Viral Gastroenteritis Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
AbbVie
Bayer AG
Sanofi S.A.
AstraZeneca Plc.
Abbott Laboratories
GlaxoSmithKline Plc.
Takeda Pharmaceutical Company Limited
EliLilly and Company
Amgen Inc
C.H.Boehringer Sohn AG & Co.KG
Daiichi Sankyo Company Limited
Regeneron Pharmaceuticals lInc.
Mylan N.V.
Astellas Pharma Inc.
Fresenius Kabi AG
Segment by Type
Antibiotic
Antacids
Antikinetic Agent
Other

Segment by Application


Hospital
Clinic
Other

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Viral Gastroenteritis Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Viral Gastroenteritis Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Viral Gastroenteritis Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Viral Gastroenteritis Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Viral Gastroenteritis Drugs introduction, etc. Viral Gastroenteritis Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Viral Gastroenteritis Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Viral Gastroenteritis Drugs Market Overview
1.1 Viral Gastroenteritis Drugs Product Overview
1.2 Viral Gastroenteritis Drugs Market Segment by Type
1.2.1 Antibiotic
1.2.2 Antacids
1.2.3 Antikinetic Agent
1.2.4 Other
1.3 Global Viral Gastroenteritis Drugs Market Size by Type
1.3.1 Global Viral Gastroenteritis Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Viral Gastroenteritis Drugs Historic Market Size Review by Type (2018-2024)
1.3.3 Global Viral Gastroenteritis Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Viral Gastroenteritis Drugs Sales Breakdown by Type (2018-2024)
1.4.2 Europe Viral Gastroenteritis Drugs Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Viral Gastroenteritis Drugs Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Viral Gastroenteritis Drugs Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Viral Gastroenteritis Drugs Sales Breakdown by Type (2018-2024)
2 Global Viral Gastroenteritis Drugs Market Competition by Company
2.1 Global Top Players by Viral Gastroenteritis Drugs Sales (2018-2024)
2.2 Global Top Players by Viral Gastroenteritis Drugs Revenue (2018-2024)
2.3 Global Top Players by Viral Gastroenteritis Drugs Price (2018-2024)
2.4 Global Top Manufacturers Viral Gastroenteritis Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Viral Gastroenteritis Drugs Market Competitive Situation and Trends
2.5.1 Viral Gastroenteritis Drugs Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Viral Gastroenteritis Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Viral Gastroenteritis Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Viral Gastroenteritis Drugs Market
2.8 Key Manufacturers Viral Gastroenteritis Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Viral Gastroenteritis Drugs Status and Outlook by Region
3.1 Global Viral Gastroenteritis Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Viral Gastroenteritis Drugs Historic Market Size by Region
3.2.1 Global Viral Gastroenteritis Drugs Sales in Volume by Region (2018-2024)
3.2.2 Global Viral Gastroenteritis Drugs Sales in Value by Region (2018-2024)
3.2.3 Global Viral Gastroenteritis Drugs Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Viral Gastroenteritis Drugs Forecasted Market Size by Region
3.3.1 Global Viral Gastroenteritis Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Viral Gastroenteritis Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Viral Gastroenteritis Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Viral Gastroenteritis Drugs by Application
4.1 Viral Gastroenteritis Drugs Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Other
4.2 Global Viral Gastroenteritis Drugs Market Size by Application
4.2.1 Global Viral Gastroenteritis Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Viral Gastroenteritis Drugs Historic Market Size Review by Application (2018-2024)
4.2.3 Global Viral Gastroenteritis Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Viral Gastroenteritis Drugs Sales Breakdown by Application (2018-2024)
4.3.2 Europe Viral Gastroenteritis Drugs Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Viral Gastroenteritis Drugs Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Viral Gastroenteritis Drugs Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Viral Gastroenteritis Drugs Sales Breakdown by Application (2018-2024)
5 North America Viral Gastroenteritis Drugs by Country
5.1 North America Viral Gastroenteritis Drugs Historic Market Size by Country
5.1.1 North America Viral Gastroenteritis Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Viral Gastroenteritis Drugs Sales in Volume by Country (2018-2024)
5.1.3 North America Viral Gastroenteritis Drugs Sales in Value by Country (2018-2024)
5.2 North America Viral Gastroenteritis Drugs Forecasted Market Size by Country
5.2.1 North America Viral Gastroenteritis Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Viral Gastroenteritis Drugs Sales in Value by Country (2024-2029)
6 Europe Viral Gastroenteritis Drugs by Country
6.1 Europe Viral Gastroenteritis Drugs Historic Market Size by Country
6.1.1 Europe Viral Gastroenteritis Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Viral Gastroenteritis Drugs Sales in Volume by Country (2018-2024)
6.1.3 Europe Viral Gastroenteritis Drugs Sales in Value by Country (2018-2024)
6.2 Europe Viral Gastroenteritis Drugs Forecasted Market Size by Country
6.2.1 Europe Viral Gastroenteritis Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Viral Gastroenteritis Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Viral Gastroenteritis Drugs by Region
7.1 Asia-Pacific Viral Gastroenteritis Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Viral Gastroenteritis Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Viral Gastroenteritis Drugs Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Viral Gastroenteritis Drugs Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Viral Gastroenteritis Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Viral Gastroenteritis Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Viral Gastroenteritis Drugs Sales in Value by Region (2024-2029)
8 Latin America Viral Gastroenteritis Drugs by Country
8.1 Latin America Viral Gastroenteritis Drugs Historic Market Size by Country
8.1.1 Latin America Viral Gastroenteritis Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Viral Gastroenteritis Drugs Sales in Volume by Country (2018-2024)
8.1.3 Latin America Viral Gastroenteritis Drugs Sales in Value by Country (2018-2024)
8.2 Latin America Viral Gastroenteritis Drugs Forecasted Market Size by Country
8.2.1 Latin America Viral Gastroenteritis Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Viral Gastroenteritis Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Viral Gastroenteritis Drugs by Country
9.1 Middle East and Africa Viral Gastroenteritis Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Viral Gastroenteritis Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Viral Gastroenteritis Drugs Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Viral Gastroenteritis Drugs Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Viral Gastroenteritis Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Viral Gastroenteritis Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Viral Gastroenteritis Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Viral Gastroenteritis Drugs Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Pfizer Viral Gastroenteritis Drugs Products Offered
10.1.5 Pfizer Recent Development
10.2 AbbVie
10.2.1 AbbVie Company Information
10.2.2 AbbVie Introduction and Business Overview
10.2.3 AbbVie Viral Gastroenteritis Drugs Sales, Revenue and Gross Margin (2018-2024)
10.2.4 AbbVie Viral Gastroenteritis Drugs Products Offered
10.2.5 AbbVie Recent Development
10.3 Bayer AG
10.3.1 Bayer AG Company Information
10.3.2 Bayer AG Introduction and Business Overview
10.3.3 Bayer AG Viral Gastroenteritis Drugs Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Bayer AG Viral Gastroenteritis Drugs Products Offered
10.3.5 Bayer AG Recent Development
10.4 Sanofi S.A.
10.4.1 Sanofi S.A. Company Information
10.4.2 Sanofi S.A. Introduction and Business Overview
10.4.3 Sanofi S.A. Viral Gastroenteritis Drugs Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Sanofi S.A. Viral Gastroenteritis Drugs Products Offered
10.4.5 Sanofi S.A. Recent Development
10.5 AstraZeneca Plc.
10.5.1 AstraZeneca Plc. Company Information
10.5.2 AstraZeneca Plc. Introduction and Business Overview
10.5.3 AstraZeneca Plc. Viral Gastroenteritis Drugs Sales, Revenue and Gross Margin (2018-2024)
10.5.4 AstraZeneca Plc. Viral Gastroenteritis Drugs Products Offered
10.5.5 AstraZeneca Plc. Recent Development
10.6 Abbott Laboratories
10.6.1 Abbott Laboratories Company Information
10.6.2 Abbott Laboratories Introduction and Business Overview
10.6.3 Abbott Laboratories Viral Gastroenteritis Drugs Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Abbott Laboratories Viral Gastroenteritis Drugs Products Offered
10.6.5 Abbott Laboratories Recent Development
10.7 GlaxoSmithKline Plc.
10.7.1 GlaxoSmithKline Plc. Company Information
10.7.2 GlaxoSmithKline Plc. Introduction and Business Overview
10.7.3 GlaxoSmithKline Plc. Viral Gastroenteritis Drugs Sales, Revenue and Gross Margin (2018-2024)
10.7.4 GlaxoSmithKline Plc. Viral Gastroenteritis Drugs Products Offered
10.7.5 GlaxoSmithKline Plc. Recent Development
10.8 Takeda Pharmaceutical Company Limited
10.8.1 Takeda Pharmaceutical Company Limited Company Information
10.8.2 Takeda Pharmaceutical Company Limited Introduction and Business Overview
10.8.3 Takeda Pharmaceutical Company Limited Viral Gastroenteritis Drugs Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Takeda Pharmaceutical Company Limited Viral Gastroenteritis Drugs Products Offered
10.8.5 Takeda Pharmaceutical Company Limited Recent Development
10.9 EliLilly and Company
10.9.1 EliLilly and Company Company Information
10.9.2 EliLilly and Company Introduction and Business Overview
10.9.3 EliLilly and Company Viral Gastroenteritis Drugs Sales, Revenue and Gross Margin (2018-2024)
10.9.4 EliLilly and Company Viral Gastroenteritis Drugs Products Offered
10.9.5 EliLilly and Company Recent Development
10.10 Amgen Inc
10.10.1 Amgen Inc Company Information
10.10.2 Amgen Inc Introduction and Business Overview
10.10.3 Amgen Inc Viral Gastroenteritis Drugs Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Amgen Inc Viral Gastroenteritis Drugs Products Offered
10.10.5 Amgen Inc Recent Development
10.11 C.H.Boehringer Sohn AG & Co.KG
10.11.1 C.H.Boehringer Sohn AG & Co.KG Company Information
10.11.2 C.H.Boehringer Sohn AG & Co.KG Introduction and Business Overview
10.11.3 C.H.Boehringer Sohn AG & Co.KG Viral Gastroenteritis Drugs Sales, Revenue and Gross Margin (2018-2024)
10.11.4 C.H.Boehringer Sohn AG & Co.KG Viral Gastroenteritis Drugs Products Offered
10.11.5 C.H.Boehringer Sohn AG & Co.KG Recent Development
10.12 Daiichi Sankyo Company Limited
10.12.1 Daiichi Sankyo Company Limited Company Information
10.12.2 Daiichi Sankyo Company Limited Introduction and Business Overview
10.12.3 Daiichi Sankyo Company Limited Viral Gastroenteritis Drugs Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Daiichi Sankyo Company Limited Viral Gastroenteritis Drugs Products Offered
10.12.5 Daiichi Sankyo Company Limited Recent Development
10.13 Regeneron Pharmaceuticals lInc.
10.13.1 Regeneron Pharmaceuticals lInc. Company Information
10.13.2 Regeneron Pharmaceuticals lInc. Introduction and Business Overview
10.13.3 Regeneron Pharmaceuticals lInc. Viral Gastroenteritis Drugs Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Regeneron Pharmaceuticals lInc. Viral Gastroenteritis Drugs Products Offered
10.13.5 Regeneron Pharmaceuticals lInc. Recent Development
10.14 Mylan N.V.
10.14.1 Mylan N.V. Company Information
10.14.2 Mylan N.V. Introduction and Business Overview
10.14.3 Mylan N.V. Viral Gastroenteritis Drugs Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Mylan N.V. Viral Gastroenteritis Drugs Products Offered
10.14.5 Mylan N.V. Recent Development
10.15 Astellas Pharma Inc.
10.15.1 Astellas Pharma Inc. Company Information
10.15.2 Astellas Pharma Inc. Introduction and Business Overview
10.15.3 Astellas Pharma Inc. Viral Gastroenteritis Drugs Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Astellas Pharma Inc. Viral Gastroenteritis Drugs Products Offered
10.15.5 Astellas Pharma Inc. Recent Development
10.16 Fresenius Kabi AG
10.16.1 Fresenius Kabi AG Company Information
10.16.2 Fresenius Kabi AG Introduction and Business Overview
10.16.3 Fresenius Kabi AG Viral Gastroenteritis Drugs Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Fresenius Kabi AG Viral Gastroenteritis Drugs Products Offered
10.16.5 Fresenius Kabi AG Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Viral Gastroenteritis Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Viral Gastroenteritis Drugs Industrial Chain Analysis
11.4 Viral Gastroenteritis Drugs Market Dynamics
11.4.1 Viral Gastroenteritis Drugs Industry Trends
11.4.2 Viral Gastroenteritis Drugs Market Drivers
11.4.3 Viral Gastroenteritis Drugs Market Challenges
11.4.4 Viral Gastroenteritis Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Viral Gastroenteritis Drugs Distributors
12.3 Viral Gastroenteritis Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Antibiotic
Table 2. Major Company of Antacids
Table 3. Major Company of Antikinetic Agent
Table 4. Major Company of Other
Table 5. Global Viral Gastroenteritis Drugs Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Viral Gastroenteritis Drugs Sales by Type (2018-2024) & (K Units)
Table 7. Global Viral Gastroenteritis Drugs Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Viral Gastroenteritis Drugs Sales by Type (2018-2024) & (US& Million)
Table 9. Global Viral Gastroenteritis Drugs Market Share in Value by Type (2018-2024)
Table 10. Global Viral Gastroenteritis Drugs Price by Type (2018-2024) & (US$/Unit)
Table 11. Global Viral Gastroenteritis Drugs Sales by Type (2024-2029) & (K Units)
Table 12. Global Viral Gastroenteritis Drugs Sales Market Share in Volume by Type (2024-2029)
Table 13. Global Viral Gastroenteritis Drugs Sales by Type (2024-2029) & (US$ Million)
Table 14. Global Viral Gastroenteritis Drugs Sales Market Share in Value by Type (2024-2029)
Table 15. Global Viral Gastroenteritis Drugs Price by Type (2024-2029) & (US$/Unit)
Table 16. North America Viral Gastroenteritis Drugs Sales by Type (2018-2024) & (K Units)
Table 17. North America Viral Gastroenteritis Drugs Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Viral Gastroenteritis Drugs Sales (K Units) by Type (2018-2024)
Table 19. Europe Viral Gastroenteritis Drugs Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Viral Gastroenteritis Drugs Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Viral Gastroenteritis Drugs Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Viral Gastroenteritis Drugs Sales (K Units) by Type (2018-2024)
Table 23. Latin America Viral Gastroenteritis Drugs Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Viral Gastroenteritis Drugs Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Viral Gastroenteritis Drugs Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Viral Gastroenteritis Drugs Sales by Company (2018-2024) & (K Units)
Table 27. Global Viral Gastroenteritis Drugs Sales Share by Company (2018-2024)
Table 28. Global Viral Gastroenteritis Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Viral Gastroenteritis Drugs Revenue Share by Company (2018-2024)
Table 30. Global Market Viral Gastroenteritis Drugs Price by Company (2018-2024) & (US$/Unit)
Table 31. Global Viral Gastroenteritis Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Viral Gastroenteritis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Viral Gastroenteritis Drugs as of 2022)
Table 34. Date of Key Manufacturers Enter into Viral Gastroenteritis Drugs Market
Table 35. Key Manufacturers Viral Gastroenteritis Drugs Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Viral Gastroenteritis Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Global Viral Gastroenteritis Drugs Sales by Region (2018-2024) & (K Units)
Table 39. Global Viral Gastroenteritis Drugs Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Viral Gastroenteritis Drugs Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Viral Gastroenteritis Drugs Sales Market Share in Value by Region (2018-2024)
Table 42. Global Viral Gastroenteritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 43. Global Viral Gastroenteritis Drugs Sales by Region (2024-2029) & (K Units)
Table 44. Global Viral Gastroenteritis Drugs Sales Market Share in Volume by Region (2024-2029)
Table 45. Global Viral Gastroenteritis Drugs Sales by Region (2024-2029) & (US$ Million)
Table 46. Global Viral Gastroenteritis Drugs Sales Market Share in Value by Region (2024-2029)
Table 47. Global Viral Gastroenteritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 48. Global Viral Gastroenteritis Drugs Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 49. Global Viral Gastroenteritis Drugs Sales by Application (2018-2024) & (K Units)
Table 50. Global Viral Gastroenteritis Drugs Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Viral Gastroenteritis Drugs Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Viral Gastroenteritis Drugs Sales Market Share in Value by Application (2018-2024)
Table 53. Global Viral Gastroenteritis Drugs Price by Application (2018-2024) & (US$/Unit)
Table 54. Global Viral Gastroenteritis Drugs Sales by Application (2024-2029) & (K Units)
Table 55. Global Viral Gastroenteritis Drugs Sales Market Share in Volume by Application (2024-2029)
Table 56. Global Viral Gastroenteritis Drugs Sales by Application (2024-2029) & (US$ Million)
Table 57. Global Viral Gastroenteritis Drugs Sales Market Share in Value by Application (2024-2029)
Table 58. Global Viral Gastroenteritis Drugs Price by Application (2024-2029) & (US$/Unit)
Table 59. North America Viral Gastroenteritis Drugs Sales by Application (2018-2024) (K Units)
Table 60. North America Viral Gastroenteritis Drugs Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Viral Gastroenteritis Drugs Sales by Application (2018-2024) (K Units)
Table 62. Europe Viral Gastroenteritis Drugs Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Viral Gastroenteritis Drugs Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Viral Gastroenteritis Drugs Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Viral Gastroenteritis Drugs Sales by Application (2018-2024) (K Units)
Table 66. Latin America Viral Gastroenteritis Drugs Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Viral Gastroenteritis Drugs Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Viral Gastroenteritis Drugs Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Viral Gastroenteritis Drugs Sales by Country (2018-2024) & (K Units)
Table 70. North America Viral Gastroenteritis Drugs Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Viral Gastroenteritis Drugs Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Viral Gastroenteritis Drugs Sales Market Share in Value by Country (2018-2024)
Table 73. North America Viral Gastroenteritis Drugs Sales by Country (2024-2029) & (K Units)
Table 74. North America Viral Gastroenteritis Drugs Sales Market Share in Volume by Country (2024-2029)
Table 75. North America Viral Gastroenteritis Drugs Sales by Country (2024-2029) & (US$ Million)
Table 76. North America Viral Gastroenteritis Drugs Sales Market Share in Value by Country (2024-2029)
Table 77. Europe Viral Gastroenteritis Drugs Sales by Country (2018-2024) & (K Units)
Table 78. Europe Viral Gastroenteritis Drugs Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Viral Gastroenteritis Drugs Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Viral Gastroenteritis Drugs Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Viral Gastroenteritis Drugs Sales by Country (2024-2029) & (K Units)
Table 82. Europe Viral Gastroenteritis Drugs Sales Market Share in Volume by Country (2024-2029)
Table 83. Europe Viral Gastroenteritis Drugs Sales by Country (2024-2029) & (US$ Million)
Table 84. Europe Viral Gastroenteritis Drugs Sales Market Share in Value by Country (2024-2029)
Table 85. Asia-Pacific Viral Gastroenteritis Drugs Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Viral Gastroenteritis Drugs Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Viral Gastroenteritis Drugs Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Viral Gastroenteritis Drugs Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Viral Gastroenteritis Drugs Sales by Region (2024-2029) & (K Units)
Table 90. Asia-Pacific Viral Gastroenteritis Drugs Sales Market Share in Volume by Region (2024-2029)
Table 91. Asia-Pacific Viral Gastroenteritis Drugs Sales by Region (2024-2029) & (US$ Million)
Table 92. Asia-Pacific Viral Gastroenteritis Drugs Sales Market Share in Value by Region (2024-2029)
Table 93. Latin America Viral Gastroenteritis Drugs Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Viral Gastroenteritis Drugs Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Viral Gastroenteritis Drugs Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Viral Gastroenteritis Drugs Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Viral Gastroenteritis Drugs Sales by Country (2024-2029) & (K Units)
Table 98. Latin America Viral Gastroenteritis Drugs Sales Market Share in Volume by Country (2024-2029)
Table 99. Latin America Viral Gastroenteritis Drugs Sales by Country (2024-2029) & (US$ Million)
Table 100. Latin America Viral Gastroenteritis Drugs Sales Market Share in Value by Country (2024-2029)
Table 101. Middle East and Africa Viral Gastroenteritis Drugs Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Viral Gastroenteritis Drugs Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Viral Gastroenteritis Drugs Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Viral Gastroenteritis Drugs Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Viral Gastroenteritis Drugs Sales by Country (2024-2029) & (K Units)
Table 106. Middle East and Africa Viral Gastroenteritis Drugs Sales Market Share in Volume by Country (2024-2029)
Table 107. Middle East and Africa Viral Gastroenteritis Drugs Sales by Country (2024-2029) & (US$ Million)
Table 108. Middle East and Africa Viral Gastroenteritis Drugs Sales Market Share in Value by Country (2024-2029)
Table 109. Pfizer Company Information
Table 110. Pfizer Introduction and Business Overview
Table 111. Pfizer Viral Gastroenteritis Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. Pfizer Viral Gastroenteritis Drugs Product
Table 113. Pfizer Recent Development
Table 114. AbbVie Company Information
Table 115. AbbVie Introduction and Business Overview
Table 116. AbbVie Viral Gastroenteritis Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. AbbVie Viral Gastroenteritis Drugs Product
Table 118. AbbVie Recent Development
Table 119. Bayer AG Company Information
Table 120. Bayer AG Introduction and Business Overview
Table 121. Bayer AG Viral Gastroenteritis Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. Bayer AG Viral Gastroenteritis Drugs Product
Table 123. Bayer AG Recent Development
Table 124. Sanofi S.A. Company Information
Table 125. Sanofi S.A. Introduction and Business Overview
Table 126. Sanofi S.A. Viral Gastroenteritis Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Sanofi S.A. Viral Gastroenteritis Drugs Product
Table 128. Sanofi S.A. Recent Development
Table 129. AstraZeneca Plc. Company Information
Table 130. AstraZeneca Plc. Introduction and Business Overview
Table 131. AstraZeneca Plc. Viral Gastroenteritis Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. AstraZeneca Plc. Viral Gastroenteritis Drugs Product
Table 133. AstraZeneca Plc. Recent Development
Table 134. Abbott Laboratories Company Information
Table 135. Abbott Laboratories Introduction and Business Overview
Table 136. Abbott Laboratories Viral Gastroenteritis Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Abbott Laboratories Viral Gastroenteritis Drugs Product
Table 138. Abbott Laboratories Recent Development
Table 139. GlaxoSmithKline Plc. Company Information
Table 140. GlaxoSmithKline Plc. Introduction and Business Overview
Table 141. GlaxoSmithKline Plc. Viral Gastroenteritis Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. GlaxoSmithKline Plc. Viral Gastroenteritis Drugs Product
Table 143. GlaxoSmithKline Plc. Recent Development
Table 144. Takeda Pharmaceutical Company Limited Company Information
Table 145. Takeda Pharmaceutical Company Limited Introduction and Business Overview
Table 146. Takeda Pharmaceutical Company Limited Viral Gastroenteritis Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. Takeda Pharmaceutical Company Limited Viral Gastroenteritis Drugs Product
Table 148. Takeda Pharmaceutical Company Limited Recent Development
Table 149. EliLilly and Company Company Information
Table 150. EliLilly and Company Introduction and Business Overview
Table 151. EliLilly and Company Viral Gastroenteritis Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. EliLilly and Company Viral Gastroenteritis Drugs Product
Table 153. EliLilly and Company Recent Development
Table 154. Amgen Inc Company Information
Table 155. Amgen Inc Introduction and Business Overview
Table 156. Amgen Inc Viral Gastroenteritis Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. Amgen Inc Viral Gastroenteritis Drugs Product
Table 158. Amgen Inc Recent Development
Table 159. C.H.Boehringer Sohn AG & Co.KG Company Information
Table 160. C.H.Boehringer Sohn AG & Co.KG Introduction and Business Overview
Table 161. C.H.Boehringer Sohn AG & Co.KG Viral Gastroenteritis Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 162. C.H.Boehringer Sohn AG & Co.KG Viral Gastroenteritis Drugs Product
Table 163. C.H.Boehringer Sohn AG & Co.KG Recent Development
Table 164. Daiichi Sankyo Company Limited Company Information
Table 165. Daiichi Sankyo Company Limited Introduction and Business Overview
Table 166. Daiichi Sankyo Company Limited Viral Gastroenteritis Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 167. Daiichi Sankyo Company Limited Viral Gastroenteritis Drugs Product
Table 168. Daiichi Sankyo Company Limited Recent Development
Table 169. Regeneron Pharmaceuticals lInc. Company Information
Table 170. Regeneron Pharmaceuticals lInc. Introduction and Business Overview
Table 171. Regeneron Pharmaceuticals lInc. Viral Gastroenteritis Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 172. Regeneron Pharmaceuticals lInc. Viral Gastroenteritis Drugs Product
Table 173. Regeneron Pharmaceuticals lInc. Recent Development
Table 174. Mylan N.V. Company Information
Table 175. Mylan N.V. Introduction and Business Overview
Table 176. Mylan N.V. Viral Gastroenteritis Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 177. Mylan N.V. Viral Gastroenteritis Drugs Product
Table 178. Mylan N.V. Recent Development
Table 179. Astellas Pharma Inc. Company Information
Table 180. Astellas Pharma Inc. Introduction and Business Overview
Table 181. Astellas Pharma Inc. Viral Gastroenteritis Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 182. Astellas Pharma Inc. Viral Gastroenteritis Drugs Product
Table 183. Astellas Pharma Inc. Recent Development
Table 184. Fresenius Kabi AG Company Information
Table 185. Fresenius Kabi AG Introduction and Business Overview
Table 186. Fresenius Kabi AG Viral Gastroenteritis Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 187. Fresenius Kabi AG Viral Gastroenteritis Drugs Product
Table 188. Fresenius Kabi AG Recent Development
Table 189. Key Raw Materials Lists
Table 190. Raw Materials Key Suppliers Lists
Table 191. Viral Gastroenteritis Drugs Market Trends
Table 192. Viral Gastroenteritis Drugs Market Drivers
Table 193. Viral Gastroenteritis Drugs Market Challenges
Table 194. Viral Gastroenteritis Drugs Market Restraints
Table 195. Viral Gastroenteritis Drugs Distributors List
Table 196. Viral Gastroenteritis Drugs Downstream Customers
Table 197. Research Programs/Design for This Report
Table 198. Key Data Information from Secondary Sources
Table 199. Key Data Information from Primary Sources
List of Figures
Figure 1. Viral Gastroenteritis Drugs Product Picture
Figure 2. Global Viral Gastroenteritis Drugs Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Viral Gastroenteritis Drugs Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Viral Gastroenteritis Drugs Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Antibiotic
Figure 6. Global Antibiotic Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Antacids
Figure 8. Global Antacids Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Antikinetic Agent
Figure 10. Global Antikinetic Agent Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of Other
Figure 12. Global Other Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Global Viral Gastroenteritis Drugs Sales by Type (2018-2029) & (US$ Million)
Figure 14. Global Viral Gastroenteritis Drugs Sales Market Share by Type in 2022 & 2029
Figure 15. North America Viral Gastroenteritis Drugs Sales Market Share in Volume by Type in 2022
Figure 16. North America Viral Gastroenteritis Drugs Sales Market Share in Value by Type in 2022
Figure 17. Europe Viral Gastroenteritis Drugs Sales Market Share in Volume by Type in 2022
Figure 18. Europe Viral Gastroenteritis Drugs Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Viral Gastroenteritis Drugs Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Viral Gastroenteritis Drugs Sales Market Share in Value by Type in 2022
Figure 21. Latin America Viral Gastroenteritis Drugs Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Viral Gastroenteritis Drugs Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Viral Gastroenteritis Drugs Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Viral Gastroenteritis Drugs Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Viral Gastroenteritis Drugs Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Viral Gastroenteritis Drugs Revenue in 2022
Figure 27. Viral Gastroenteritis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Hospital
Figure 29. Global Hospital Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Clinic
Figure 31. Global Clinic Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Other
Figure 33. Global Other Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Global Viral Gastroenteritis Drugs Sales by Application (2018-2029) & (US$ Million)
Figure 35. Global Viral Gastroenteritis Drugs Sales Market Share by Application in 2022 & 2029
Figure 36. North America Viral Gastroenteritis Drugs Sales Market Share in Volume by Application in 2022
Figure 37. North America Viral Gastroenteritis Drugs Sales Market Share in Value by Application in 2022
Figure 38. Europe Viral Gastroenteritis Drugs Sales Market Share in Volume by Application in 2022
Figure 39. Europe Viral Gastroenteritis Drugs Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Viral Gastroenteritis Drugs Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Viral Gastroenteritis Drugs Sales Market Share in Value by Application in 2022
Figure 42. Latin America Viral Gastroenteritis Drugs Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Viral Gastroenteritis Drugs Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Viral Gastroenteritis Drugs Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Viral Gastroenteritis Drugs Manufacturing Cost Structure
Figure 47. Viral Gastroenteritis Drugs Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries